WHO ICTRP trial
Morphologic response to chemotherapy containing bevacizumab in patients with…
JPRN-UMIN000022171 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000022171 |
|---|---|
| Public title | Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS) |
| Scientific title | Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: a retrospective study(WJOG4407GSS) - Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases |
| Primary sponsor | West Japan Oncology Group |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Others,meta-analysis etc |
| Phase | Not applicable |
| Countries | Japan |
| Conditions | metastatic colorectal cancer |
| Registration date | Feb 5, 2016 |
| Target size | 70 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: